Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05571033 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral Palsy

Study acronym: SRC-CP
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 26, 2023 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 5 to 12
    • Eligibility criteria shortened, about 138 words
    • Secondary endpoints revised (27)
    v6
  2. Primary completion date: Dec 31, 2023 to Dec 31, 2025v5
  3. Primary completion date: Dec 31, 2025 to Dec 31, 2023v4
  4. Re-verified, no change to tracked fieldsv3
  5. Enrollment target: 12 to 5v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
12 adults with spastic CP will complete 6 baseline sessions and 24 down conditioning sessions held 3 times/week. All clinical and physiological assessments collected at baseline will be reassessed after study completion, and follow ups after 2 weeks, 1 month and 3 months. The soleus H reflex (electric analogue of the stretch reflex) will be elicited in all sessions. In each session, participants will complete 20 baseline trials and 225 down conditioning trials to decrease the magnitude of the H-Reflex.
Trial Details
NCT Number NCT05571033
Lead Sponsor Burke Medical Research Institute
Conditions
(from sponsor)		 Cerebral Palsy, Spastic Cerebral Palsy
Related terms Cerebral Palsy, Reflex, Abnormal
Enrollment 12 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov